Tag - QTTB

Markets

Clear Street starts Q32 Bio at buy; PT $38

Clear Street initiated coverage of Q32 Bio (NASDAQ: QTTB) with a “buy” rating and price target of $38.00. The stock closed at $8.77 on September 25. Q32 Bio is a clinical-stage biotechnology company developing therapies...

September 28, 2026

Executive Moves

Q32 Bio names Drs. José Trevejo as CMO and Ellie Hershberger as CDO

Q32 Bio (NASDAQ: QTTB) has announced the appointment of José Trevejo, MD, PhD, as chief medical officer (CMO) and Ellie Hershberger, PharmD, as chief development officer (CDO). Prior to joining Q32 Bio, Dr. Trevejo...

September 14, 2026

Tag - QTTB

Clear Street starts Q32 Bio at buy; PT $38

Q32 Bio names Drs. José Trevejo as CMO and Ellie Hershberger as CDO

Subscribe